Marketing-authorisation holder · United States
Viatris
29 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
29 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 29
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ASTEPRO0.137MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.2055MG/SPRAY · Spray, metered | Azelastine | United States | Not marketed | 2008 |
| CARDURA1mg base | 2mg base | 4mg base | 8mg base · Tablet | Doxazosin | United States | Marketed | 1990 |
| CARDURA XL4mg base | 8mg base · Tablet, extended release | Doxazosin | United States | Marketed | 2005 |
| CORTIFOAM10% · Aerosol, metered | Hydrocortisone | United States | Marketed | 1982 |
| DILANTIN100mg extended | 30mg extended · Capsule | Phenytoin | United States | Marketed | 1976 |
| DILANTIN-125125mg/5ml · Suspension | Phenytoin | United States | Marketed | 1953 |
| DILANTIN-3030mg/5ml · Suspension | Phenytoin | United States | Not marketed | 1953 |
| EDLUAR10mg | 5mg · Tablet | Zolpidem | United States | Marketed | 2009 |
| ELESTRIN0.06% (0.87gm/activation) · Gel, metered | Estradiol | United States | Marketed | 2006 |
| EPI E Z PEN JR0.15mg/delivery · Injectable | Epinephrine | United States | Not marketed | 1987 |
| EPIPEN0.3mg/delivery · Injectable | Epinephrine | United States | Marketed | 1987 |
| EPIPEN E Z PEN0.3mg/delivery · Injectable | Epinephrine | United States | Not marketed | 1987 |
| EPIPEN JR.0.15mg/delivery · Injectable | Epinephrine | United States | Marketed | 1987 |
| GEODON20mg base | 40mg base | 60mg base | 80mg base · Capsule | Ziprasidone | United States | Marketed | 2001 |
| GEODON20mg base/vial · Powder | Ziprasidone | United States | Marketed | 2002 |
| MUSE0.125mg | 0.25mg | 0.5mg | 1mg · Suppository | Alprostadil | United States | Not marketed | 1996 |
| NEURONTIN600mg | 800mg · Tablet | Gabapentin | United States | Marketed | 1998 |
| NEURONTIN100mg | 300mg | 400mg · Capsule | Gabapentin | United States | Marketed | 1993 |
| NEURONTIN250mg/5ml · Solution | Gabapentin | United States | Marketed | 2000 |
| NITROSTAT0.3mg | 0.4mg | 0.6mg · Tablet | Nitroglycerin | United States | Marketed | 2000 |
| NORVASC10mg base | 2.5mg base | 5mg base · Tablet | Amlodipine | United States | Marketed | 1992 |
| REVATIO10mg base/ml · For suspension | Sildenafil | United States | Not marketed | 2012 |
| REVATIO20mg base · Tablet | Sildenafil | United States | Marketed | 2005 |
| REVATIO10mg base/12.5ml (eq 0.8mg base/ml) · Solution | Sildenafil | United States | Marketed | 2009 |
| TOBI300mg/5ml · Solution | Tobramycin | United States | Marketed | 1997 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 29 | 29 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.